Millagaha Gedara Nuwan Indika, Xu Xuan, DeLong Robert, Aryal Santosh, Jaberi-Douraki Majid
1DATA Consortium, Kansas State University Olathe, Olathe, KS 66061, USA.
Department of Mathematics, K-State, 22201 W Innovation Dr. Olathe, Olathe, KS 66061, USA.
Cancers (Basel). 2021 Sep 1;13(17):4417. doi: 10.3390/cancers13174417.
This study presents a new way to investigate comprehensive trends in cancer nanotechnology research in different countries, institutions, and journals providing critical insights to prevention, diagnosis, and therapy. This paper applied the qualitative method of bibliometric analysis on cancer nanotechnology using the PubMed database during the years 2000-2021. Inspired by hybrid medical models and content-based and bibliometric features for machine learning models, our results show cancer nanotechnology studies have expanded exponentially since 2010. The highest production of articles in cancer nanotechnology is mainly from US institutions, with several countries, notably the USA, China, the UK, India, and Iran as concentrated focal points as centers of cancer nanotechnology research, especially in the last five years. The analysis shows the greatest overlap between nanotechnology and DNA, RNA, iron oxide or mesoporous silica, breast cancer, and cancer diagnosis and cancer treatment. Moreover, more than 50% of the information related to the keywords, authors, institutions, journals, and countries are considerably investigated in the form of publications from the top 100 journals. This study has the potential to provide past and current lines of research that can unmask comprehensive trends in cancer nanotechnology, key research topics, or the most productive countries and authors in the field.
本研究提出了一种新方法,用于调查不同国家、机构和期刊中癌症纳米技术研究的综合趋势,为癌症预防、诊断和治疗提供关键见解。本文在2000年至2021年期间,利用PubMed数据库对癌症纳米技术应用了文献计量分析的定性方法。受混合医学模型以及机器学习模型基于内容和文献计量特征的启发,我们的研究结果表明,自2010年以来,癌症纳米技术研究呈指数级增长。癌症纳米技术领域文章产量最高的主要来自美国机构,有几个国家,特别是美国、中国、英国、印度和伊朗,作为癌症纳米技术研究的集中焦点,尤其是在过去五年。分析表明,纳米技术与DNA、RNA、氧化铁或介孔二氧化硅、乳腺癌以及癌症诊断和癌症治疗之间的重叠度最高。此外,与关键词、作者、机构、期刊和国家相关的信息中,超过50%是以排名前100的期刊发表的形式进行了大量研究。本研究有潜力提供过去和当前的研究方向,揭示癌症纳米技术的综合趋势、关键研究课题,或该领域最具生产力的国家和作者。